Adams Asset Advisors, LLC has reduced its stake in Calumet (CLMT) by nearly 2 million shares, valued at approximately $50.3 million, according to an SEC filing dated April 27, 2026. Despite this sale, Calumet’s position in Adams’ portfolio increased in value by $12.5 million due to a significant 194% rise in CLMT shares over the past year, outperforming the S&P 500 by 164 percentage points. Calumet remains the firm’s largest holding, representing 12.9% of its assets under management.
This transaction signals profit-taking rather than a loss of confidence in Calumet, which has shown robust growth, reporting $4.1 billion in revenue and a $293.3 million adjusted EBITDA for 2025. The company is also advancing its renewable fuels segment, backed by a substantial Department of Energy loan guarantee. However, investors should remain cautious, as Calumet continues to operate at a loss and is subject to the cyclical volatility typical of the energy sector.
For market professionals, this development underscores the importance of monitoring profit-taking behaviors in high-performing stocks and considering diversified energy ETFs for broader exposure in the specialty chemicals and renewable fuels sectors.
Source: fool.com